Expert panelists provide an overview of diagnosing and treating plaque psoriasis, addressing specific challenges in patient management.
EP. 7: Moderate to Severe Plaque Psoriasis: What is the Standard of Care?January 10th 2022
Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.
EP. 9: Bimekizumab’s Potential in Moderate-to-Severe Plaque PsoriasisJanuary 17th 2022
A focused discussion on the benefit of bimekizumab, an IL-17A/IL-17F inhibitor, in the setting of moderate to severe plaque psoriasis.
EP. 11: Factors in Selecting Biologic Therapy for Moderate to Severe Plaque PsoriasisJanuary 24th 2022
Panelists share which factors they use to determine optimal therapy in the moderate to severe plaque psoriasis setting.